The purpose of this study is to compare the safety and efficacy of the Laminar System (Investigational device) to commercially available left atrial appendage closure (LAAC) devices, such as Watchman FLX and Amulet (Control devices) in patients with non-valvular atrial fibrillation (NVAF) who are deemed appropriate for LAAC to reduce the risk of stroke and systemic embolism.
What is the full name of this clinical trial?
Laminar Left Atrial Appendage Elimination Pivotal IDE Study